INTRODUCTION
============

Casein kinases are among the most abundant serine/threonine protein kinases found in eukaryotic cells ([@B15]; [@B42]; [@B27]; [@B64]; [@B8]) and generally recognize substrate motifs consisting of acidic or phosphorylated amino acid residues ([@B1]; [@B17]; [@B18]; [@B45], [@B44]; [@B22]). Members of the casein kinase 1 (CK1) family have been implicated in multiple cellular processes, including regulation of autophagy, DNA repair, circadian rhythm, ribosome assembly, intracellular trafficking, meiotic progression, and Wnt signaling ([@B37]; [@B57]; [@B19]; [@B50]). CK1 kinases share highly related catalytic domains (53--98% sequence identity) that consist of a bilobed structure with a smaller N-terminal lobe consisting primarily of β-sheets and a larger, primarily α-helical C-terminal lobe ([@B7]; [@B69]; [@B39]). However, CK1 family members have divergent C-terminal noncatalytic domains that are thought to dictate intracellular localization and govern catalytic activity ([@B23]; [@B39], [@B40]; [@B9]; [@B20]; [@B2]; [@B14]; [@B24]; [@B31]; [@B46]). Indeed, some CK1 isoforms are anchored to membranes via C-terminal palmitoylation ([@B67]; [@B65]; [@B3]; [@B62]).

Hhp1 and Hhp2 (hereafter referred to as Hhp1/2) are the sole soluble CK1s in *Schizosaccharomyces pombe* and are orthologues of *Saccharomyces cerevisiae* Hrr25p and human CK1δ and CK1ε (hereafter referred to as CK1δ/ε) ([@B16]; [@B29]). In addition to functioning redundantly in meiosis, DNA damage repair, and mitotic commitment ([@B16]; [@B56]; [@B10]), Hhp1/2 are essential for preventing cytokinesis during a mitotic stress imposed by microtubule depolymerization ([@B32]). In this checkpoint pathway, Hhp1/2 function redundantly upstream of the ubiquitin ligase Dma1 to inhibit the septation initiation network (SIN) ([@B49]; [@B26]b), a *hippo*-related signaling pathway localized at the spindle pole body (SPB) that triggers cytokinesis ([@B33]; [@B34]; [@B61]). Specifically, Hhp1/2 phosphorylate the SIN scaffold Sid4 at T275 and S278 to create a docking site for Dma1's FHA domain ([@B32]). Dma1 then concentrates at SPBs and ubiquitinates Sid4, also a scaffold for Polo-like kinase Plo1, to inhibit Plo1's SPB localization and ability to activate the SIN ([@B26]; [@B33]).

In addition to other subcellular localizations, Hhp1/2, as well as Hrr25p and human CK1δ/ε, localize to the SPB or its equivalent in vertebrates, the centrosome ([@B30]; [@B24]; [@B32]; [@B52]). Interaction with AKAP450 and the γ-tubulin complex is reported to be important for anchoring CK1δ and Hrr25p to the centrosome and SPB, respectively ([@B60]; [@B52]). However, the residues within CK1 enzymes required for SPB/centrosome recruitment are unknown, as is the SPB tether in *S. pombe*.

In this work, we establish that Hhp1/2 localize throughout the cell cycle to the SPB and also to the nucleus and cell division site, with Hhp2 showing additional localization to cell tips. We report that the catalytic domains of Hhp1/2 are sufficient to support this localization pattern independently of enzymatic function. Further, we define conserved residues at the base of the Hhp1 catalytic domain necessary for SPB localization. Mutation of these residues eliminates Hhp1's SPB localization and mitotic checkpoint function by disrupting the interaction with the core SPB protein Ppc89 ([@B55]) but does not affect other critical Hhp1 functions. We also find that the centrosomal targeting information in human CK1δ/ε is analogously contained within their respective kinase domains, indicating conservation of this localization mechanism from yeast to humans. This study provides novel insight into how specific docking residues within the catalytic domain of protein kinases can direct them to subcellular locations to control substrate phosphorylation and downstream signaling.

RESULTS
=======

Hhp1/2 localization during a normal and perturbed cell cycle
------------------------------------------------------------

Both Hhp1 and Hhp2 localize to SPBs, and either is sufficient to promote the Dma1-mediated mitotic checkpoint that delays cytokinesis ([@B32]). For determination of their intracellular distribution throughout the cell cycle and during a mitotic arrest, each was tagged at its endogenous C-terminus with mNeonGreen (mNG) ([@B59]; [@B68]) and coimaged with the SPB protein Sid4-RFP ([@B11]). Both Hhp1 and Hhp2 localize to the nucleus and the division site in addition to SPBs; Hhp2 was also detected at cell tips ([Figure 1A](#F1){ref-type="fig"}). By immunoblotting whole-cell lysates from a strain producing both enzymes tagged with green fluorescent protein (GFP), we determined that Hhp1 is more abundant than Hhp2 (Supplemental Figure S1A), consistent with the relative protein levels determined by quantitative mass spectrometry ([@B41]; [@B8]) and the more severe growth defects and phenotypes associated with the deletion of *hhp1^+^* relative to *hhp2^+^* (Supplemental Figure S1, B--D) ([@B16]; [@B29]; [@B6]; [@B8]; [@B12]). To better define the localization of Hhp1/2 during the mitotic checkpoint signaling window, we performed time-lapse imaging of cells progressing through mitosis. Hhp1-mNG and Hhp2-mNG localized to the SPB and nucleus throughout mitosis, and also to the division site following the completion of spindle elongation with comparable timing (Supplemental Figure S1, E and F). These data indicate that the spatial and temporal distributions of Hhp1 and Hhp2 are similar but not identical.

![Intracellular localization patterns of Hhp1/2. (A) Live-cell imaging of Hhp1-mNG and Hhp2-mNG with Sid4-RFP. (B--D) Hhp1-mNG (B) and Hhp2-mNG (C, D) were imaged in prometaphase-arrested and wild-type mitotic *sad1-mCherry* or *sad1-mCherry hhp1∆* cells. Representative inverted grayscale images are shown in the left panels with quantitation to the right. mCh, mCherry. Scale bars: 5 µm. Values are represented as mNG/mCherry intensity ratios. \*\*\*, *p* \< 0.005, \*\*\*\*, *p* \< 0.001 determined using Student's *t* test. ns, not significant. Error bars represent SEM.](mbc-29-1664-g001){#F1}

When the mitotic checkpoint is activated by preventing microtubule polymerization in the *nda3-KM311*β-tubulin mutant ([@B63]), Sid4 is phosphorylated by Hhp1/2, and Hhp1 increases in intensity at SPBs ([@B32]) ([Figure 1B](#F1){ref-type="fig"}). By coimaging with the SPB marker Sad1-mCherry in checkpoint-activated and unperturbed mitotic cells, we found that Hhp2 intensity at duplicated but unseparated SPBs was also increased in checkpoint-activated cells, but only if they lacked Hhp1 ([Figure 1, C and D](#F1){ref-type="fig"}). These results indicate that both Hhp1/2 can accumulate at SPBs during the checkpoint.

Hhp1/2 catalytic domains direct SPB localization and checkpoint function
------------------------------------------------------------------------

To determine the mechanism of Hhp1/2 SPB targeting, we first defined the regions of the enzymes necessary for this localization. Hhp1/2 contain conserved N-terminal catalytic domains and kinase domain extensions (KDEs) that are conserved among mammalian but not *S. cerevisiae* CK1 family members (reviewed in [@B38]) ([Figure 2A](#F2){ref-type="fig"}). Given that both Hhp1/2 localize to SPBs and participate in checkpoint signaling, we anticipated that homologous sequences dictated these functions and that their unrelated C-termini were not involved. Accordingly, Hhp1/2 C-terminal truncations, constructed by inserting sequences encoding GFP in the endogenous *hhp1/2* loci to produce Hhp1-(1-296)-GFP and Hhp2-(1-295)-GFP ([Figure 2B](#F2){ref-type="fig"}), both colocalized with Sid4-RFP at SPBs ([Figure 2C](#F2){ref-type="fig"}). Moreover, Hhp1-(1-296)-GFP and Hhp2-(1-295)-GFP recapitulated all other subcellular localizations of the full-length proteins ([Figure 2C](#F2){ref-type="fig"}). The C-terminus of Hhp1 fused to GFP was not targeted to any particular subcellular location, although it was produced in cells (Supplemental Figure S2, A and B), indicating that the C-terminus is neither necessary nor sufficient for SPB localization of Hhp1/2.

![The C-termini of Hhp1/2 are dispensable for their functions. (A) Schematic diagrams of Hhp1/2 with relative positions of N-terminal extensions (N, green), kinase domains (blue), kinase domain extensions (KDE, yellow), and unrelated C-termini in red or purple indicated, drawn to scale. (B) Anti-GFP immunoblots of whole-cell extracts prepared from untagged and the indicated GFP-tagged strains. Anti-PSTAIRE (Cdc2) immunoblots served as protein loading controls. (C) Live-cell imaging of endogenously tagged Hhp1-(1-296)-GFP and Hhp2-(1-295)-GFP with Sid4-RFP. Scale bars: 5 µm. (D) Serial 10-fold dilutions of the indicated strains were spotted on YE plates and incubated at the indicated temperatures. (E) In vitro kinase assays of recombinant MBP-Hhp1, MBP-Hhp1-(1-296), MBP-Hhp2, and MBP-Hhp2-(1-295) detected by Coomassie blue (CB) staining of SDS--PAGE gels, with casein as substrate. Phosphorylated casein was detected by autoradiography (^32^P). (F) Sid4 from the indicated strains was immunoprecipitated from denatured cell lysates, treated with phosphatase, and visualized by immunoblotting.](mbc-29-1664-g002){#F2}

To ascertain the functionality of the C-terminal truncation mutants of Hhp1/2, we performed growth, in vitro kinase, and mitotic checkpoint assays. First, we found that each of the *hhp1/2* C-terminal truncation mutants integrated as the sole *hhp1/2* allele in cells rescued the severe growth defect of the double-deletion mutant in vivo ([Figure 2D](#F2){ref-type="fig"}). Consistent with this finding and previous reports ([@B23]; [@B9]; [@B20]), recombinant Hhp1/2 C-terminal truncation mutants phosphorylated the exogenous substrate casein in vitro even more robustly than the full-length proteins ([Figure 2E](#F2){ref-type="fig"}). Importantly, we found that the truncation mutants were sufficient to inhibit the SIN during the mitotic checkpoint. GFP-tagged Hhp1 and Hhp2 C-terminal truncations accumulated at SPBs during a mitotic checkpoint arrest (Supplemental Figure S2, C and D), and Sid4 was appropriately ubiquitinated ([Figure 2F](#F2){ref-type="fig"}). Taken together, these data indicate that the C-termini of Hhp1/2 are dispensable for their SPB localization and function during the Dma1-mediated mitotic checkpoint.

Because the KDE of CK1δ was reported to mediate its centrosomal localization ([@B24]), we tested whether Hhp1/2 KDEs influence SPB targeting. Further C-terminal truncations of Hhp1/2 were made such that only the predicted catalytic domains (Hhp1-(1-280)-GFP and Hhp2-(1-278)-GFP) were produced from endogenous loci (Supplemental Figure S3A). While these Hhp1/2 truncation mutants were still SPB targeted, as evidenced by colocalization with Sid4-RFP (Supplemental Figure S3B), functional tests revealed that they only partially rescued the severe growth defect of the double-deletion mutant in vivo (Supplemental Figure S3C), and they did not support mitotic checkpoint signaling as assayed by Sid4 ubiquitination (Supplemental Figure S3D). This loss of in vivo function is likely due to significantly reduced kinase activity (Supplemental Figure S3, E and F). We conclude that, while the KDEs of Hhp1/2 are required for their full enzymatic function, SPB targeting information is contained within the Hhp1/2 catalytic domains*.*

Hhp1/2 localize to SPBs independent of catalytic activity
---------------------------------------------------------

It was previously reported that the kinase activity of CK1δ and of Hrr25 is necessary for their proper centrosomal and SPB localization, respectively ([@B47]; [@B51],b). Because the Hhp1-(1-280)-GFP and Hhp2-(1-278)-GFP mutants had severely reduced activity but were still able to localize, we hypothesized that, in contrast, Hhp1/2 kinase activity may not impact their SPB targeting. We generated catalytically inactive mutants of each enzyme (Hhp1-K40R and Hhp2-K41R) and verified their inactivity in vitro ([Figure 3A](#F3){ref-type="fig"}). When produced at the endogenous loci as sole gene copies tagged with mNG in cells, these mutants mimicked null alleles in growth and Sid4 ubiquitination assays (Supplemental Figure S4, A and B), although they were produced at wild-type levels as determined by immunoblotting ([Figure 3B](#F3){ref-type="fig"}) and by measuring whole-cell fluorescence intensities (Supplemental Figure S4, C and D). Coimaging of Sid4-RFP and Hhp1-(K40R)-mNG or Hhp2-(K41R)-mNG showed that both catalytically inactive mutants localized to SPBs ([Figure 3C](#F3){ref-type="fig"}), indicating that Hhp1/2 kinase activity is not necessary for SPB localization. Furthermore, Hhp1-(K40R)-mNG colocalized with Sid4-RFP in a *hhp2∆* background, and Hhp2-(K41R)-mNG colocalized with Sid4-RFP in a *hhp1∆* background. Taken together, these data indicate that *hhp2* is not required for the SPB localization of Hhp1 and vice versa.

![Kinase activity of Hhp1/2 is not required for SPB localization. (A) In vitro kinase assays of recombinant MBP-Hhp1-(K40R) and MBP-Hhp2-(K41R) detected by CB staining of SDS--PAGE gels, with casein as substrate. Phosphorylated casein was detected by autoradiography. (B) Anti-GFP immunoblot of whole-cell extracts prepared from untagged and the indicated GFP-tagged strains. Anti-PSTAIRE antibody served as loading control for lysates. (C) Live-cell imaging of endogenously tagged Hhp1-(K40R)-mNG with Sid4-RFP in *wildtype* and *hhp2∆* cells along with Hhp2-(K41R)-mNG with Sid4-RFP in *wildtype* and *hhp1∆* cells. Scale bars: 5 µm.](mbc-29-1664-g003){#F3}

The kinase domains of CK1δ/ε dictate centrosomal localization
-------------------------------------------------------------

CK1δ/ε, the vertebrate orthologues of Hhp1/2, localize to the centrosome ([@B47]; [@B30]) ([Figure 4A](#F4){ref-type="fig"}). To determine whether the intrinsic cues necessary for Hhp1/2 SPB localization are conserved in CK1δ/ε, we made C-terminal truncations of CK1δ/ε analogous to those of Hhp1/2 that did or did not contain the KDE (Supplemental Figure S5A). These truncation mutants or wild-type versions of the proteins were then expressed in RPE-1 cells as N-terminal GFP fusions ([Figure 4A](#F4){ref-type="fig"} and Supplemental Figure S5B). In the majority of transfected cells, all three versions of the proteins colocalized with the centrosomal marker γ-tubulin, although truncation of the KDE from either protein resulted in a lower percentage of centrosomal localization compared with wild type or truncations including the KDEs ([Figure 4, A and B](#F4){ref-type="fig"}). These data support the idea that, as in Hhp1/2, the centrosome-targeting information is contained within the CK1δ/ε kinase domains, and we hypothesize that the KDE may impart stability to their association with centrosomes.

![The centrosomal targeting information of CK1δ/ε is located within the kinase domain. RPE-1 cells were transiently transfected with GFP N-terminal fusions to full length or truncations of CK1δ and CK1ε. Cells were fixed with 100% methanol and stained with γ-tubulin (magenta) and DAPI (blue). (A) Localization of full-length protein and truncation mutants in RPE-1 cells. (B) Quantification of the colocalization between γ-tubulin and full-length proteins or truncation mutants. (C) Localization of full-length GFP-CK1δ and GFP-CK1ε catalytically inactive mutants. (D, E) Quantification of the colocalization between γ-tubulin and GFP-CK1δ (D) or GFP-CK1ε (E) wild type or catalytically inactive mutants. For B, D, and E, 100 cells per experiment. *n* = 3. \*, *p* \< 0.05, \*\*, *p* \< 0.01, \*\*\*, *p* \< 0.005, \*\*\*\*, *p* \< 0.001, *p* values determined using ANOVA; ns, not significant. Error bars represent SEM. Scale bars: 15 μm.](mbc-29-1664-g004){#F4}

We next tested whether kinase activity was important for CK1δ/ε centrosomal localization. K38R mutations in both enzymes render them inactive ([@B20]) (Supplemental Figure S5C). When these mutations were expressed in RPE-1 cells as GFP fusions (Supplemental Figure S5D), both colocalized at centrosomes with γ-tubulin to the same extent as wild type ([Figure 4](#F4){ref-type="fig"}, C--E), indicating that protein kinase activity is dispensable for their centrosomal targeting. Taken together, these data indicate that soluble CK1 family members use their catalytic domains to associate with the major microtubule organizing centers.

Residues in the C-terminal lobe of the Hhp1 kinase domain are required for SPB localization
-------------------------------------------------------------------------------------------

To probe the mechanism by which one of these enzymes targets spindle poles, we identified residues in the Hhp1 catalytic domain that were necessary. To do this, we performed a comparative analysis of Hhp1 and its paralogue, Cki2. Cki2 does not localize to SPBs; Cki2 C-terminally tagged with GFP localized to vacuolar membranes (Supplemental Figure S6, A and B, top), as previously reported ([@B43]). Furthermore, a C-terminally tagged mutant of Cki2 lacking the predicted palmitoylation sites (Cki2-(1-429)-GFP) ([@B62]) localized to the nucleus, cytoplasm, and division site, but it still did not localize to SPBs (Supplemental Figure S6, A and B, bottom), indicating that Cki2 lacks SPB-targeting information.

To detect differences between Hhp1 and Cki2, we generated structural models of the kinase domains of Hhp1 and Cki2 ([Figure 5A](#F5){ref-type="fig"} and Supplemental Figure S6C) using the Protein Homology/analogY Recognition Engine v. 2.0 (Phyre^2^) ([@B36]). A comparison revealed 19 surface residues of Cki2 that differed in charge potential from analogous residues on Hhp1 (Supplemental Figure S6, C and D). To determine whether any of these residues mediate SPB localization, the corresponding residues in Hhp1 were mutated to either mimic the Cki2 residue or reverse the charge of the Hhp1 residue, and the resultant mutants were integrated at the *hhp1* endogenous locus and tagged at their C-termini with mNG. Of the 14 mutants tested, only Hhp1-(R261E)-mNG and Hhp1-(R272E K273E)-mNG failed to localize to SPBs ([Figure 5B](#F5){ref-type="fig"} and Supplemental Figure S6D). Hhp1-(R261E)-mNG and Hhp1-(R272E K273E)-mNG were still recruited to other subcellular locations, including the nucleus and division site. Both mutant proteins were produced at levels similar to those of wild type ([Figure 5C](#F5){ref-type="fig"}). Interestingly, these mutants retained function, as measured by their ability to support wild-type *S. pombe* growth and phosphorylate casein in vitro (Supplemental Figure S6, E and F).

![Residues at the base of the Hhp1 catalytic domain are critical for SPB localization. (A) Homology model of Hhp1 catalytic domain generated from Phyre^2^ software and visualized with MacPymol. Residues critical for Hhp1 SPB localization are in blue. (B) Live-cell imaging of endogenously tagged Hhp1-(R261E)-mNG and Hhp1-(R272E K273E)-mNG with Sid4-RFP. Scale bars: 5 μm. (C) Anti-GFP immunoblot of whole-cell extracts prepared from the indicated strains. Anti-PSTAIRE immunoblots served as protein loading controls.](mbc-29-1664-g005){#F5}

Interaction with Ppc89 mediates Hhp1/2 SPB localization
-------------------------------------------------------

Though Sid4 is an SPB-localized Hhp1/2 target ([@B32]), Sid4 is not required for Hhp1 ([@B32]) or Hhp2 (Supplemental Figure S7A) SPB localization, and it is not known which protein(s) tethers Hhp1/2 to SPBs. However, Hhp1/2 copurify with multiple SPB proteins, including a central component of the SPB, Ppc89, which also secures Sid4 at the SPB ([@B55]; [@B32]). Ppc89 is required for Hhp1 ([@B32]) and Hhp2 (Supplemental Figure S7B) SPB localization, and *ppc89* interacts with *hhp1* ([@B66]) and *hhp2* in a yeast two-hybrid assay ([Figure 6, A--C](#F6){ref-type="fig"}). We further determined that a C-terminal truncation of Ppc89 supports two-hybrid interactions with *hhp1/2* ([Figure 6A](#F6){ref-type="fig"}), indicating that the interaction site is distinct from that of Sid4, which interacts with the Ppc89 C-terminus ([@B55]).

![Basic residues within the kinase domain of Hhp1 are critical for interaction with the SPB protein Ppc89. (A, B) *S. cerevisiae* strain PJ69-4A was cotransformed with plasmids expressing *hhp1/2* or their variants, *hhp1-(1-296)*, or *hhp2-(1-295)* and indicated sections of *ppc89*. KD = kinase domain. Black boxes in A indicate regions of predicted coiled-coil. Transformants were scored for growth on −Trp −Leu −His plates supplemented with 5 mM 3-AT. Pluses indicate strong growth and minuses indicate no growth. (C) Bar graph shows β-galactosidase activity of the indicated bait and prey plasmids tested for growth in B (represented in relative light units). Each assay was performed in triplicate. \*\*\*\*, *p* \< 0.001 determined using ANOVA. Error bars represent SEM.](mbc-29-1664-g006){#F6}

We next tested whether the residues that were critical for Hhp1 SPB localization affected interaction with Ppc89. We found that neither *hhp1-R261E* nor *hhp1-R272E K273E* interacted with *ppc89* in the two-hybrid assay ([Figure 6, B and C](#F6){ref-type="fig"}). Thus, these residues likely mediate an interaction with Ppc89, which may position Hhp1/2 proximal to their mitotic checkpoint substrate, Sid4.

Hhp1/2 SPB localization is required for checkpoint signaling
------------------------------------------------------------

To test the hypothesis that CK1 must be present at SPBs to execute its checkpoint function, we examined the ability of Hhp1-R261E and Hhp1-R272E K273E to prevent septation when a mitotic checkpoint is imposed*.* Because either Hhp1 or Hhp2 can redundantly activate the Dma1-mediated mitotic checkpoint, we combined *hhp1-R261E* and *hhp1-R272E K273E* with an *hhp2∆* mutant to analyze mitotic checkpoint function. We found that the tubulin mutant *nda3-KM311, nda3-KM311 hhp1-(R272E K273E)* and *nda3-KM311 hhp1-(R261E)* delayed septation, whereas *nda3-KM311 hhp1-(R272E K273E) hhp2∆* and *nda3-KM311 hhp1-(R261E) hhp2∆* could not hold the arrest ([Figure 7, A and B](#F7){ref-type="fig"}). Because of its ability to inhibit the SIN via Sid4 ubiquitination, overexpression of *dma1* is lethal ([@B26]); however, *hhp1-(R261E) hhp2∆* and *hhp1-(R272E K273E) hhp2∆* mutants were refractory to *dma1* overexpression--induced lethality ([Figure 7C](#F7){ref-type="fig"}). Also consistent with checkpoint failure, Sid4 ubiquitination was not detected in checkpoint-activated *hhp1-(R261E) hhp2∆* or *hhp1-(R272E K273E) hhp2∆* cells ([Figure 7D](#F7){ref-type="fig"}). Taken together, these data indicate that Hhp1/2 localization to SPBs is critical for their role in mitotic checkpoint signaling.

![Hhp1 SPB localization is required for mitotic checkpoint function. (A, B) The indicated strains were synchronized in S phase with hydroxyurea and shifted to 19°C to activate the spindle checkpoint, and septation indices were measured periodically for 9 h. (C) Overexpression of *dma1* from the *nmt41* promoter in wild type, *hhp1-(R261E) hhp2∆*, or *hhp1-(R272E K273E) hhp2∆* mutant cells. Growth of the transformants was observed on agar plates in the presence (repression) or absence (derepression) of thiamine. (D) Sid4 from the indicated strains was immunoprecipitated from denatured cell lysates, treated with phosphatase, and visualized by immunoblotting.](mbc-29-1664-g007){#F7}

DISCUSSION
==========

The mechanisms governing CK1 enzyme targeting to specific intracellular locales are not well defined. The *S. pombe* CK1 enzymes Hhp1/2 are the most upstream components yet identified in the Dma1-mediated mitotic checkpoint that stalls cytokinesis when the mitotic spindle is disrupted. To define how they access their SPB substrate Sid4 in this pathway, we determined how they localize to SPBs and whether this was an essential feature of the checkpoint pathway. We found that Hhp1/2 catalytic domains but not enzymatic activities provide the localization cue and that this targeting strategy is conserved in human CK1δ/ε localization to centrosomes. In further probing the specific requirements for spindle pole localization in one of these enzymes, we identified positively charged residues at the base of the Hhp1 catalytic domain that support interaction with a key SPB scaffold, Ppc89. This interaction is necessary for Hhp1 SPB association, Sid4 phosphorylation, and a mitotic checkpoint response, but not for other functions carried out by this enzyme to promote cell proliferation. Our findings reveal a conserved mechanism by which CK1 enzymes can be tailored to perform a specific function at a discrete subcellular location and time.

Hhp1/2 have overlapping but not identical subcellular localizations
-------------------------------------------------------------------

Hhp1/2 have redundant roles in the Dma1-dependent mitotic checkpoint ([@B32]), and deletion of either enzyme also renders cells sensitive to multiple types of DNA-damaging agents ([@B16]; [@B6]; [@B12]), observations that are congruent with these enzymes having similar functions. However, in addition to detecting Hhp1/2 in the nucleus, in accord with their known roles in DNA damage repair, and at SPBs and the cell division site, we found that Hhp2 but not Hhp1 is present at cell tips. This observation raises the possibility that these enzymes could have, in addition to common functions, variable, specialized roles that remain to be determined.

Kinase domains mediate spindle pole recruitment of Hhp1/2 and CK1δ/ε
--------------------------------------------------------------------

Because neither *hhp1* nor *hhp2* are essential genes (the double-deletion mutant can also be maintained; e.g., [Figure 2D](#F2){ref-type="fig"}), we were able to clearly define the requirements for their SPB localization without the potentially confounding effects of overexpression and/or the presence of wild-type enzymes. By making gene-replacement strains producing C-terminal truncations, we pinpointed the SPB-targeting information of Hhp1/2 to within their kinase domains. In contrast, the noncatalytic C-terminus of *S. cerevisiae* Hrr25 was reported to be necessary for SPB localization ([@B52]). This difference may be explained by a "central domain" in the Hrr25 kinase that is not conserved in the *S. pombe* or mammalian CK1 enzymes and that has been found to confer functions specific to *Saccharomyces* species ([@B70]). Interestingly, we found that the cell tip localization of Hhp2 is also supported by its kinase domain. Because of the high degree of sequence similarity between the Hhp1/2 kinase domains ([@B16]), it seems likely that a subtle difference in the enzymes' structures imparts this distinction in localization pattern.

Conflicting evidence has been reported regarding the requirements for CK1δ/ε centrosomal targeting. While one report indicated that the kinase domain of human CK1δ is necessary and sufficient for proper subcellular localization ([@B47]), another suggested that a C-terminal centrosomal localization sequence (equivalent to what we have termed the KDE) in mouse CK1δ was necessary and sufficient for centrosomal localization ([@B24]). Here, we found that the catalytic domains of CK1δ/ε (lacking the KDEs) are sufficient for centrosome targeting, although constructs containing the KDEs are more stably localized.

In the course of characterizing the *hhp1/2* C-terminal truncation mutants, we found that removal of the C-terminal tails, but not the KDEs, led to increased catalytic activity toward an exogenous substrate in vitro. These findings agree with previous results demonstrating that phosphorylation of the C-terminal noncatalytic domain by intramolecular autophosphorylation inhibits CK1 catalytic activity ([@B23]; [@B39], [@B40]; [@B9]; [@B20]). Interestingly, *hhp1-(1-296)* and *hhp2-(1-295)* did not display any growth defects, signifying that the autoinhibition observed in vitro may not be essential in vivo, or that hypermorphic Hhp1/2 activity is not detrimental to cells. Removal of the KDEs of Hhp1/2, however, led to decreased function in vitro and in vivo*.* It is possible that the KDEs interact with the C-terminal lobe of the kinase domain, as does the central domain of Hrr25p ([@B70]). Such an interaction could influence the structure and function of Hhp1/2 and CK1δ/ε, thereby explaining defects in both localization and activity of mutants lacking KDEs.

Hhp1/2 and CK1δ/ε localize to spindle poles independently of kinase activity
----------------------------------------------------------------------------

We found that Hhp1/2 and CK1δ/ε do not require kinase activity for SPB or centrosomal localization. This differs from what has been reported for Hrr25 ([@B51],b) and one report on CK1δ ([@B47]). However, our results agree with another report ([@B54]) indicating that CK1δ/ε kinase activity is dispensable for centrosomal targeting. Because Hhp1/2 are the only protein kinases that function upstream of Dma1 in the Dma1-mediated mitotic checkpoint ([@B32]), our results indicate that Hhp1/2 do not need to phosphoprime their tether(s) at spindle poles. Thus, to accumulate at SPBs/centrosomes, these enzymes may use scaffolds whose accessibility or abundance is modulated.

Notably, only one scaffolding protein, AKAP450, has been implicated in mediating CK1 localization to centrosomes ([@B60]). In other signaling pathways, scaffolds are essential organizing platforms that recruit a kinase and its substrate to the same intracellular location. For example, mitogen-activated protein kinase cascades and protein kinase A pathways depend on scaffolding proteins to maintain kinase specificity ([@B58]). In the context of Hhp1/2, which are involved in multiple cellular processes and have potentially constitutive activity, binding the scaffold Pcp89 may compartmentalize a subset of Hhp1/2 from a wider cellular population to direct CK1 enzymes to a specialized signaling complex. Therefore, interaction with Ppc89 may 1) provide an additional level of specificity by localizing Hhp1/2 and its substrate Sid4 to the appropriate site of action, 2) generate a stronger signal by concentrating Hhp1/2 and Sid4, and/or 3) allow for coordination of the Hhp1/2-Dma1-dependent mitotic checkpoint with other signaling pathways that are centered at the SPB.

Defining the CK1 SPB-binding interface
--------------------------------------

Our results, along with previous work, indicate that CK1 catalytic domains moonlight as protein interaction domains for kinase localization. Hhp1 requires conserved basic residues on its C-terminal lobe to interact with the SPB. In only one prior case have residues in the catalytic domain of CK1 enzymes been implicated in docking interactions. Specifically, residues in the N-terminal lobe of the Hrr25p catalytic domain, together with its central domain, bind the monopolin subunit Mam1 and promote phosphorylation of monopolin's kinetochore receptor Dsn1 ([@B53]; [@B70]). Our findings therefore represent an important advance for the understanding of CK1 kinase domain--mediated subcellular targeting. Though new for CK1, several other catalytic domains of broadly acting protein kinases are known to associate with scaffolds. As one example, the MAPK Fus3 is recruited and also allosterically regulated by the scaffold protein Ste5 ([@B13]; [@B5]). Thus, Ppc89 may not only scaffold Hhp1/2 at the SPB but also modulate their catalytic activity.

Our work demonstrates that CK1 interaction with SPBs is essential for mitotic checkpoint function in *S. pombe*. Similarly, CK1δ centrosomal localization has been reported to be required for Wnt-3a--dependent neuritogenesis and proper ciliogenesis ([@B24]; [@B25]); thus, specific subcellular localization of CK1 enzymes is essential for mediating proper cellular signaling. Future work on the role of these enzymes at the SPB/centrosome is expected to reveal additional functions that are coordinated from this important cellular signaling nexus.

MATERIALS AND METHODS
=====================

Yeast strains, media, and genetic methods
-----------------------------------------

*Schizosaccharomyces pombe* strains used in this study (Supplemental Table S1) were grown in yeast extract (YE) media ([@B48]). Crosses were performed in glutamate medium ([@B48]), and strains were constructed by tetrad analysis. *hhp1*, *hhp1-K40R*, *hhp1-R261E*, *hhp1-R272E K273E*, *hhp2*, and *cki2* were tagged endogenously at the 3′ end of their open reading frames (ORFs) with *GFP:kan^R^* or *mNG:kan^R^* using pFA6 cassettes as previously described ([@B4]). G418 (100 μg/ml; Sigma-Aldrich, St. Louis, MO) in YE media was used for selecting *kan^R^* cells. mNG, a recently reported GFP derived from the lancelet *Branchiostoma lanceolatum*, was chosen for imaging experiments because of its superior brightness ([@B59]; [@B68]). A lithium acetate transformation method ([@B35]) was used for introducing sequences encoding tags, and integration of tags was verified using whole-cell PCR and/or microscopy. Tagged *hhp1/2* alleles were fully functional as determined by growth assays and their ability to support Sid4 ubiquitination ([Figure 2, D and F](#F2){ref-type="fig"}, and Supplemental Figures S3, C and D, and S5E). Introduction of tagged loci into other genetic backgrounds was accomplished using standard *S. pombe* mating, sporulation, and tetrad-dissection techniques. Fusion proteins were expressed from their native promoters at their normal chromosomal locus unless otherwise indicated. For *hhp1* and *hhp2* gene replacements, haploid *hhp1::ura4+* and *hhp2::ura4+* strains were transformed with linear *hhp1* and *hhp2* mutant gene fragments (digested with *Bam*HI and *Pst*I from pIRT2-*hhp1* and pIRT2-*hhp2* plasmids) using standard lithium acetate transformations. Integrants were selected based on resistance to 1.5 mg/ml 5-fluoroorotic acid (Fisher Scientific) and validated by colony PCR using primers homologous to endogenous sequences that flank the genomic clone within pIRT2 in combination with those within the ORF. All constructs and integrants were sequenced to ensure their accuracy.

For serial-dilution growth assays, cells were cultured in liquid YE at 25°C, three serial 10-fold dilutions starting at 4 × 10^6^ cells/ml were made, 4 μl of each dilution was spotted on YE plates, and cells were grown at the indicated temperatures for 3--4 d. The GFP-Hhp1 (aa 280--365) fragment was cloned into a pREP81-GFP vector using *Nde*I and *Bam*HI restriction sites. This construct and a construct with GFP alone were expressed in a wild-type strain under the control of the *nmt81* promoter. Cells were grown in media containing thiamine and then washed into media without thiamine to induce protein production, then grown for 22 h at 32°C before imaging. For imaging experiments, temperature-sensitive mutants were grown at 25°C and then shifted to 36°C before imaging. Cold-sensitive *nda3*-*km311* strains were grown at 32°C and shifted to 19°C for 6 h, and images were acquired immediately at room temperature. All other strains were grown and imaged at 25°C.

Cell culture, transfection, fixation, and antibody staining
-----------------------------------------------------------

RPE-1 cells were cultured in DMEM/F12 supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin. Cells were seeded 24 h before transfection onto 25-mm coverslips that were contained in a six-well plate. Six hours before transfection, cells were incubated in serum-free media. Plasmid DNA (1.5 μg) was transfected into cells using Lipofectamine 3000 (Life Technologies). Cells were allowed to grow for an additional 24 h before fixation. Cells were washed once with cold 1X PBS and once with 100% cold methanol, followed by fixation with 100% cold methanol for 15 min at −20°C. Cells were then washed three times with 0.1% TBST (1× Tris-buffered saline, 0.1% Tween 20), followed by blocking with AbDil (0.1% TBST + 2% bovine serum albumin) for 10 min. Cells were stained with anti-γ-tubulin antibody (Sigma-Aldrich, GTU88; 1:500) in AbDil overnight at 4°C, washed three times with 0.1% TBST, followed by 4′,6-diamidino-2-phenylindole (DAPI; 0.1 μg/μl) and secondary antibody staining (Alexa Fluor 594 goat-anti mouse immunoglobulin G \[IgG\] \[H+L\], ThermoFisher; 1:500) for 45 min at 22°C. Coverslips were mounted on slides using ProLong Gold antifade mounting media (Invitrogen by ThermoFisher Scientific). Each experiment was performed in triplicate.

Molecular biology methods
-------------------------

All plasmids were generated by standard molecular biology techniques. *hhp1* and *hhp2* genes including 500 base pairs upstream and downstream of the ORFs were amplified by PCR and ligated into a PCR-Blunt vector (Life Technologies) and then subcloned into a pIRT2 vector ([@B28]). *hhp1* and *hhp2* mutants were created by mutagenizing pIRT2-plasmids containing *hhp1^+^* and *hhp2^+^* using a QuikChange site-directed mutagenesis kit (Agilent Technologies). Plasmids were validated by DNA sequencing.

The ORF of CK1δ was amplified by PCR from a plasmid (CK1δ pGEX-6p-2) kindly provided by Fanni Gergely (University of Cambridge). V405 4HA-CK1ε, a gift from David Virshup (Duke University Medical School) (Addgene plasmid \#13724), was used as a template for PCR amplification of the CK1ε ORF. Each PCR product was cloned into pEGFP-C1, and the correct sequence was validated by DNA sequencing. Mutant CK1δ/ε variants were made using the QuikChange site-directed mutagenesis kit (Agilent Technologies) and confirmed by DNA sequencing.

*Schizosaccharomyces pombe* protein methods
-------------------------------------------

Cell pellets were frozen in a dry ice/ethanol bath and lysed by bead disruption in NP-40 lysis buffer under denaturing SDS lysis conditions as previously described ([@B21]), except with the addition of a complete protease inhibitor mixture (Calbiochem). Cell pellets for Hhp1 and Hhp2 immunoblots were lysed by bead disruption using a FastPrep cell homogenizer (MP Biomedicals). For analysis of Sid4 ubiquitination, Sid4 was immunoprecipitated under denaturing SDS conditions using Sid4 antiserum ([@B32]). Proteins were separated on a 4--12% Bis-Tris gel (Life Technologies), transferred to Immobilon-P polyvinylidene fluoride (Millipore) membrane, and immunoblotted with anti-GFP (Roche, 1:1000), anti-Sid4 (1:2000), and fluorescent anti-mouse and anti-rabbit secondary antibodies (Li-Cor Biosciences) according to the manufacturers' instructions.

Microscopy methods
------------------

Live-cell images of *S. pombe* cells were acquired using a Personal DeltaVision microscope system (Applied Precision) that includes an Olympus IX71 microscope, 60×/1.42 NA Plan-Apo and 100×/1.40 NA UPlanSApo objectives, a Photometrics CoolSnap HQ2 camera, and softWoRx imaging software. Images in figures are maximum-intensity projections of *z*-sections spaced at 0.2--0.5 µm. Images used for quantification were not deconvolved and were sum projected. Other images were deconvolved with 10 iterations. Time-lapse imaging was performed on cells in log phase using a microfluidics perfusion system (CellASIC ONIX; EMD Millipore). Cells were loaded into Y04C plates for 5 s at 8 psi, and YE liquid medium was flowed into the chamber at 5 psi throughout imaging. Quantitative analysis of microscopy data was performed using Fiji (a version of ImageJ software available at <https://fiji.sc)>. For comparison of populations of cells for all genotypes, cells were imaged on the same day with the same microscope parameters. The average mNG fluorescence intensity of each protein at SPBs was measured in at least 20 cells. For all intensity measurements, the background was subtracted by creating a region of interest (ROI) in the same image where there were no cells. The raw intensity of the background was divided by the area of the background, which was multiplied by the area of the ROI. This number was subtracted from the raw integrated intensity of that ROI. For SPB intensity quantification, an ROI was drawn around the SPB and measured for raw integrated density; for whole-cell intensity quantification, an ROI was drawn around the entire cell. The average mCherry fluorescence intensities were measured similarly, and final values for each cell are expressed as mNG/mCherry ratios. Measurements for the 20 cells in each group were averaged for statistical analysis using a two-tailed Student's *t* test or analysis of variance (ANOVA) implemented in Prism 6 (GraphPad Software). All statistical ANOVAs used Tukey's post hoc analysis.

In addition, for comparison of two populations of cells within the same field of view, one population was incubated with fluorescently conjugated lectin (Sigma-Aldrich), which labels cell walls. Specifically, 1 µl of a 5 mg/ml stock of tetramethylrhodamine-lectin in water was added to 1 ml of cells for a final concentration of 5 µg/ml. Cells were then incubated for 10 min at room temperature, washed three times, and resuspended in media. The lectin-labeled cell population and unlabeled cell population were mixed 1:1 immediately before imaging. The reciprocal labeling of populations was also performed to account for any signal bleed-through. The fluorescence intensity of the SPB was quantified, and background fluorescence was subtracted ([@B68]).

In vitro kinase assays
----------------------

MBP-Hhp1 and MBP-Hhp2 fusion proteins were purified on amylose beads (New England Biolabs) in column buffer (20 mM Tris, pH 7.0, 150 mM NaCl, 2 mM EDTA, and 0.1% NP40) and eluted with maltose (10 mM). Kinase reactions were performed with 500 ng kinase, 500 ng casein, 10 μM ATP plus 1 µCi γ-\[^32^P\]ATP in kinase buffer (50 mM Tris, pH 7.5, 10 mM MgCl~2~, and 5 mM dithiothreitol) in 20 µl at 30°C for 30 min. Reactions were quenched by adding SDS--PAGE sample buffer, and proteins were separated by SDS--PAGE. Phosphorylated proteins were visualized by autoradiography, and relative protein quantities were assessed by Coomassie blue staining relative to known standards using Odyssey software (Li-Cor Biosciences). Kinetic assays were performed using recombinant MBP-Hhp1 and MBP-Hhp2 fusion proteins treated for 2 h with lambda phosphatase (New England Biolabs). These kinase reactions were performed with 0.25 μM of kinase, 25 μM casein, 5 μM cold ATP, 2 μCi \[γ^32^P\]-ATP in CK1 kinase buffer. Reactions were quenched at different time points by adding SDS sample buffer, and proteins were separated by SDS--PAGE. Phosphorylated proteins were visualized and quantitated using an FLA7000IP Typhoon Storage Phosphorimager (GE Healthcare Life Sciences). Kinetic measurements were calculated using Prism 6 software. Relative protein quantities were assessed by Coomassie blue staining.

Two-hybrid analyses
-------------------

Two-hybrid experiments were performed as described previously ([@B66]). *hhp1* and *ppc89*, cloned into pDEST DB and pDEST AD vectors, respectively, were generously provided by Haiyuan Yu (Cornell University). These or fragments thereof were cotransformed into *S. cerevisiae* strain PJ69-4A. Leu^+^ and Trp^+^ transformants were selected and then scored for positive interactions by streaking onto synthetic dextrose plates containing 5 mM 3-amino-1,2,4-triazole and lacking tryptophan, leucine, and histidine. β-Galactosidase reporter enzyme activity in the two-hybrid strains was measured using the Galacto-Star chemiluminescent reporter assay system according to the manufacturer's instructions (Applied Biosystems, Foster City, CA), except that cells were lysed by glass bead disruption. Each experiment was performed in triplicate. Reporter assays were recorded on a Multi-Detection Microplate Reader (Bio-TEK Instruments).

Checkpoint assay
----------------

*Schizosaccharomyces pombe* cells were synchronized in S phase using hydroxyurea (HU; Sigma) at a final concentration of 12 mM for 3--3.5 h at 32°C. Cells were then filtered into HU-free media and immediately incubated at 19°C to activate the spindle checkpoint. Cells were fixed in 70% ethanol, and septation indices were measured periodically for 10 h by methyl blue staining of the septa.

Protein modeling
----------------

Structural models of Hhp1 and Cki2 were generated using the Protein Homology/analogY Recognition Engine v. 2.0 (Phyre^2^) ([@B36]). Homology models were generated from crystal structures of the kinase domains of Hhp1 and Cki2 homologues.
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